Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Blasco

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 4, 2013
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluationPascal Furet, Vito Guagnano, Robin A Fairhurst, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2014
Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria modelSuresh B Lakshminarayana, Céline Freymond, Christoph Fischli, et al.
Journal of Virology|November 22, 2013
Activation of peripheral blood mononuclear cells by dengue virus infection depotentiates balapiravirYen-Liang Chen, Nahdiyah Abdul Ghafar, Ratna Karuna, et al.
European Journal of Medicinal Chemistry|February 10, 2009
Design of novel aminopyrrolidine factor Xa inhibitors from a screening hitKatrin Groebke Zbinden, Lilli Anselm, David W Banner, et al.
Plos One|August 21, 2014
Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosisSuresh B Lakshminarayana, Helena I M Boshoff, Joseph Cherian, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2010
Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitorsCarole Pissot-Soldermann, Marc Gerspacher, Pascal Furet, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2015
Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitorsRobin A Fairhurst, Marc Gerspacher, Patricia Imbach-Weese, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitorsMarc Gerspacher, Pascal Furet, Carole Pissot-Soldermann, et al.
Journal of Medicinal Chemistry|May 2, 2022
Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase InhibitorRobin A Fairhurst, Pascal Furet, Patricia Imbach-Weese, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2009
Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABA(A) alpha5 inverse agonist seriesGuido Achermann, Theresa M Ballard, Francesca Blasco, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|June 4, 2013
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluationPascal Furet, Vito Guagnano, Robin A Fairhurst, et al.
Antimicrobial Agents and Chemotherapy|December 10, 2014
Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria modelSuresh B Lakshminarayana, Céline Freymond, Christoph Fischli, et al.
Journal of Virology|November 22, 2013
Activation of peripheral blood mononuclear cells by dengue virus infection depotentiates balapiravirYen-Liang Chen, Nahdiyah Abdul Ghafar, Ratna Karuna, et al.
European Journal of Medicinal Chemistry|February 10, 2009
Design of novel aminopyrrolidine factor Xa inhibitors from a screening hitKatrin Groebke Zbinden, Lilli Anselm, David W Banner, et al.
Plos One|August 21, 2014
Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosisSuresh B Lakshminarayana, Helena I M Boshoff, Joseph Cherian, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2010
Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitorsCarole Pissot-Soldermann, Marc Gerspacher, Pascal Furet, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2015
Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitorsRobin A Fairhurst, Marc Gerspacher, Patricia Imbach-Weese, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitorsMarc Gerspacher, Pascal Furet, Carole Pissot-Soldermann, et al.
Journal of Medicinal Chemistry|May 2, 2022
Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase InhibitorRobin A Fairhurst, Pascal Furet, Patricia Imbach-Weese, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2009
Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABA(A) alpha5 inverse agonist seriesGuido Achermann, Theresa M Ballard, Francesca Blasco, et al.
Pageof 3